Verenium announced it has entered into a definitive merger agreement with BASF, a leading chemicals company, under which BASF will commence a cash tender offer for all of the outstanding shares of Verenium's common stock. The board of directors for both companies have unanimously approved the transaction. Under the terms of the Verenium merger agreement, holders of outstanding shares of Verenium's common stock will receive $4.00 per share.
If you own the common stock of Verenium and are concerned about the transaction and would like to learn more about how to begin a cost free corporate review of this merger, please fill out the contact form on this web page or call Attorney George Pressly at 1-(800)-631-6234.
State security laws provide shareholders a no cost means to question a proposed sale of a publicly traded company. This review process is deemed a shareholder class action and affords at times shareholders an avenue to investigate fully the proposed transaction. At minimum, this process often obtains answers to the above questions. If you own the common stock of Verenium and if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please fill out the contact form on this web page.